CFAM
Center For Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
1,908
-71
| -4% | -$12.5K | 0.21% | 89 |
|
|
2025
Q1 | $415K | Buy |
1,979
+66
| +3% | +$13.8K | 0.25% | 84 |
|
|
2024
Q4 | $340K | Sell |
1,913
-31
| -2% | -$5.51K | 0.22% | 85 |
|
|
2024
Q3 | $384K | Hold |
1,944
| – | – | 0.23% | 86 |
|
|
2024
Q2 | $333K | Sell |
1,944
-152
| -7% | -$26.1K | 0.22% | 94 |
|
|
2024
Q1 | $382K | Sell |
2,096
-252
| -11% | -$45.9K | 0.31% | 76 |
|
|
2023
Q4 | $364K | Sell |
2,348
-353
| -13% | -$54.7K | 0.33% | 72 |
|
|
2023
Q3 | $403K | Buy |
2,701
+1,183
| +78% | +$176K | 0.4% | 60 |
|
|
2023
Q2 | $205K | Sell |
1,518
-3,397
| -69% | -$458K | 0.19% | 98 |
|
|
2023
Q1 | $783K | Buy |
4,915
+20
| +0.4% | +$3.19K | 0.77% | 33 |
|
|
2022
Q4 | $791K | Buy |
4,895
+345
| +8% | +$55.8K | 0.74% | 36 |
|
|
2022
Q3 | $611K | Sell |
4,550
-122
| -3% | -$16.4K | 0.61% | 40 |
|
|
2022
Q2 | $716K | Buy |
4,672
+2,373
| +103% | +$364K | 0.66% | 35 |
|
|
2022
Q1 | $373K | Buy |
2,299
+176
| +8% | +$28.6K | 0.29% | 70 |
|
|
2021
Q4 | $287K | Buy |
2,123
+83
| +4% | +$11.2K | 0.21% | 89 |
|
|
2021
Q3 | $220K | Sell |
2,040
-28
| -1% | -$3.02K | 0.19% | 97 |
|
|
2021
Q2 | $233K | Buy |
2,068
+101
| +5% | +$11.4K | 0.2% | 92 |
|
|
2021
Q1 | $213K | Buy |
1,967
+56
| +3% | +$6.06K | 0.2% | 84 |
|
|
2020
Q4 | $205K | Buy |
+1,911
| New | +$205K | 0.2% | 80 |
|